Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Verici Dx (VRCI) Share Price

Price 0.375p on 26-06-2026 at 16:30:00
Change 0.00p 0%
Buy 0.40p
Sell 0.35p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Sell 829.00 at 0.35p
Day's Volume: 22,440
Last Close: 0.375p
Open: 0.375p
ISIN: GB00BM8HZD43
Day's Range 0.375p - 0.375p
52wk Range: 0.375p - 1.25p
Market Capitalisation: £8.30m
VWAP: 0.397551p
Shares in Issue: 2.21b

Sector: Medicine and Biotech

Listed In: FTSE AIM All-Share,

Verici Dx (VRCI) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 829 0.35p Ordinary
 12:46:19 - 26-Jun-26
Buy* 1 0.395p Ordinary
 12:33:16 - 26-Jun-26
Buy* 1 0.395p Ordinary
 12:29:50 - 26-Jun-26
Sell* 270 0.35p Ordinary
 12:24:37 - 26-Jun-26
Buy* 5,623 0.40p Ordinary
 11:05:33 - 26-Jun-26
Buy* 655 0.40p SI Trade
 11:05:32 - 26-Jun-26
Buy* 300 0.40p SI Trade
 11:05:32 - 26-Jun-26
Buy* 3,160 0.40p SI Trade
 11:05:32 - 26-Jun-26
Buy* 1,000 0.40p SI Trade
 11:05:32 - 26-Jun-26
Buy* 507 0.40p SI Trade
 11:05:32 - 26-Jun-26
See more Verici Dx trades

Verici Dx (VRCI) Share Price History

Time period:
to
Date Open High Low Close Volume
25th Jun 2026 (Thu) 0.375 0.375 0.375 0.375 2,032,242
24th Jun 2026 (Wed) 0.375 0.375 0.375 0.375 4,046,050
23rd Jun 2026 (Tue) 0.375 0.375 0.375 0.375 25,489
22nd Jun 2026 (Mon) 0.375 0.375 0.375 0.375 29,777
19th Jun 2026 (Fri) 0.375 0.375 0.375 0.375 35,575
18th Jun 2026 (Thu) 0.375 0.375 0.375 0.375 138,807
17th Jun 2026 (Wed) 0.375 0.375 0.375 0.375 1,792,844
16th Jun 2026 (Tue) 0.375 0.375 0.375 0.375 479,437
15th Jun 2026 (Mon) 0.375 0.375 0.375 0.375 1,045,808
12th Jun 2026 (Fri) 0.375 0.375 0.375 0.375 41,714
11th Jun 2026 (Thu) 0.375 0.375 0.375 0.375 5,441,262
10th Jun 2026 (Wed) 0.375 0.375 0.375 0.375 1,636,520
9th Jun 2026 (Tue) 0.375 0.375 0.375 0.375 7,422,031
8th Jun 2026 (Mon) 0.375 0.40 0.40 0.40 3,649,512
5th Jun 2026 (Fri) 0.425 0.425 0.375 0.375 11,255,018
4th Jun 2026 (Thu) 0.425 0.425 0.425 0.425 980,795
3rd Jun 2026 (Wed) 0.425 0.425 0.425 0.425 2,543,262
2nd Jun 2026 (Tue) 0.475 0.475 0.425 0.425 1,327,800
1st Jun 2026 (Mon) 0.425 0.425 0.425 0.425 577,238
29th May 2026 (Fri) 0.425 0.425 0.425 0.425 811,008
28th May 2026 (Thu) 0.425 0.425 0.425 0.425 21,255
27th May 2026 (Wed) 0.425 0.425 0.425 0.425 513,122
26th May 2026 (Tue) 0.425 0.425 0.425 0.425 1,791,187
See more Verici Dx price history

Verici Dx (VRCI) Regulatory News

Date Source Headline
25th Jun 2026 4:08 pm RNS Holding(s) in Company
24th Jun 2026 5:24 pm RNS Holding(s) in Company
24th Jun 2026 4:34 pm RNS Holding(s) in Company
24th Jun 2026 12:37 pm RNS Holding(s) in Company
24th Jun 2026 11:13 am RNS Holding(s) in Company
24th Jun 2026 9:06 am RNS Holding(s) in Company
24th Jun 2026 7:00 am RNS New York State clinical lab certification received
23rd Jun 2026 4:08 pm RNS Holding(s) in Company
22nd Jun 2026 3:15 pm RNS Result of General Meeting
19th Jun 2026 3:11 pm RNS Holding(s) in Company
See more Verici Dx regulatory news

Verici Dx (VRCI) Share News

TRADING UPDATES: Tullow Oil makes partial notes repayment

24th Jun 2026 13:40

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

TRADING UPDATES: Unicorn Mineral; Helix Exploration agree acquisitions

8th Jun 2026 15:59

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on xxxday and not separately reported by Alliance News: Read More

IN BRIEF: Verici Dx says study validates PTRA in kidney transplants

19th May 2026 16:16

Verici Dx PLC - Cardiff, Wales-based developer of advanced clinical diagnostics for organ transplants - Announces the publication of a peer-reviewed clinical validation study of its pre-transplant rejection assessment test, which is commercially marketed by Thermo Fisher Scientific Inc. Says the test outperformed conventional risk assessment tools in the ability to predict early acute rejection in the first two months following a kidney transplant, which enables clinicians to identify patients who may benefit from the safe minimisation of therapy while effectively managing the risk of early rejection. Says current methods, which involve standardised immunosuppressive regimens with more aggressive therapy for patients seen as high-risk, "have limited predictive value, which can lead to unnecessary over-suppression and risks related to toxicity, infections and malignancy." Read More

WINNERS & LOSERS: Riverstone redeems shares; IQE raises GBP513 million

28th Apr 2026 11:20

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday. Read More

EARNINGS AND TRADING: Norcros sales up; eEnergy eyes record first-half

16th Apr 2026 14:38

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

See more Verici Dx news
FTSE 100 Latest
Value10,508.02
Change-21.87

Login to your account

Forgot Password?

Not Registered